Dr Ashley Kirsten Shepard, DPM - Medicare Podiatrist in Hartford, CT

Dr Ashley Kirsten Shepard, DPM is a medicare enrolled "Podiatrist" provider in Hartford, Connecticut. She went to Temple University School Of Medicine and graduated in 1996 and has 28 years of diverse experience with area of expertise as Podiatry. She is a member of the group practice Hartford Healthcare Medical Group Specialists Pllc and her current practice location is 85 Seymour St, Ste 409, Hartford, Connecticut. You can reach out to her office (for appointments etc.) via phone at (860) 547-0616.

Dr Ashley Kirsten Shepard is licensed to practice in Connecticut (license number 000777) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1790770733.

Contact Information

Dr Ashley Kirsten Shepard, DPM
85 Seymour St, Ste 409,
Hartford, CT 06106
(860) 547-0616
(860) 524-2655



Healthcare Provider's Profile

Full NameDr Ashley Kirsten Shepard
GenderFemale
SpecialityPodiatry
Experience28 Years
Location85 Seymour St, Hartford, Connecticut
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ashley Kirsten Shepard attended and graduated from Temple University School Of Medicine in 1996
  NPI Data:
  • NPI Number: 1790770733
  • Provider Enumeration Date: 09/15/2005
  • Last Update Date: 07/12/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 6103970314
  • Enrollment ID: I20090821000202

Medical Identifiers

Medical identifiers for Dr Ashley Kirsten Shepard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1790770733NPI-NPPES
2V3380OtherCTHEALTH NET
0322890MedicaidMA
077700OtherCTCTCARE
030000777CT01OtherCTANTHEM BCBS
1176045 002OtherCTCIGNA
3225079OtherCTAETNA
P2883933OtherCTOXFORD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
213E00000XPodiatrist 000777 (Connecticut)Primary
213ES0103XPodiatrist - Foot & Ankle Surgery 000777 (Connecticut)Secondary
213ER0200XPodiatrist - Radiology 000777 (Connecticut)Secondary
213EP1101XPodiatrist - Primary Podiatric Medicine 000777 (Connecticut)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Hartford HospitalHartford, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Hartford Healthcare Medical Group Specialists Pllc31738662411138

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ashley Kirsten Shepard allows following entities to bill medicare on her behalf.
Provider NameHartford Hospital
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1407806391
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000700

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more Medical News

› Verified 7 days ago

Provider NameHartford Hospital
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1770696643
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000752

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more Medical News

› Verified 7 days ago

Provider NameHartford Healthcare Medical Group Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1043561301
PECOS PAC ID: 1153573902
Enrollment ID: O20121201000007

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more Medical News

› Verified 7 days ago

Provider NameHartford Healthcare Medical Group Specialists Pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1023584216
PECOS PAC ID: 3173866241
Enrollment ID: O20190514001441

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ashley Kirsten Shepard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ashley Kirsten Shepard, DPM
85 Seymour St, Ste 409,
Hartford, CT 06106

Ph: (860) 547-0616
Dr Ashley Kirsten Shepard, DPM
85 Seymour St, Ste 409,
Hartford, CT 06106

Ph: (860) 547-0616

News Archive

Compugen announces validation of IDD discovery platform for identification of cell penetrating peptides

Compugen Ltd. announced today the development and validation of its Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides. Compugen also announced that as part of the validation process for the new platform, more than twenty novel peptides, predicted and selected in silico, demonstrated the predicted cell penetrating properties in initial experimental validation studies.

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

Northeastern University researcher reports finding epicenter of brain's prediction

In recent years, sci­en­tists have dis­cov­ered the human brain works on pre­dic­tions, con­trary to the pre­vi­ously accepted theory that it reacts to the sen­sa­tions it picks up from the out­side world. Experts say humans' reac­tions are in fact the body adjusting to pre­dic­tions the brain is making based on the state of our body the last time it was in a sim­ilar situation.

Getting to the bottom of hospital bills' 'gross charges'

Robert D'Amicodatri had two strokes, complicated by seizures, and rang up $374,741 in charges at Crozer-Chester Medical Center early in 2009. Three years later, in February, the Delaware County hospital sued him for $241,321, the balance after an insurance policy paid $20,998 and the hospital reduced his bill by $112,422 for a reason it has declined to explain.

$7.5 million Queensland diabetes action plan to roll

According to the latest $7.5 million diabetes action plan, nearly 8,000 people across the Ipswich region who are living with the disease and have not been diagnosed will be helped. Diabetes is growing at a shocking rate with more than 50 Queenslanders diagnosed with the condition every day. Diabetes Australia Queensland says more than 8,000 people in the Ipswich and West Moreton region have been diagnosed with diabetes. Another 8,000 people have the condition but remain undiagnosed.

Read more News

› Verified 7 days ago


Podiatrist in Hartford, CT

Eric Lui, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 85 Seymour St, Suite 409, Hartford, CT 06106
Phone: 860-547-0616    Fax: 860-524-2655
Connecticut Surgical Group, Pc
Podiatrist
Medicare: Not Enrolled in Medicare
Practice Location: 85 Seymour St, Ste 409, Hartford, CT 06106
Phone: 860-547-0616    Fax: 860-524-2655
Connecticut Foot Specialists Pc
Podiatrist
Medicare: Not Enrolled in Medicare
Practice Location: 1000 Asylum Avenue, Suite 2100, Hartford, CT 06105
Phone: 860-714-3668    Fax: 860-714-8123
Catherine Jacobs,
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Hartford, CT 06105
Phone: 860-714-5911    
Dr. Eric Myles Kosofsky, DPM
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 999 Asylum Ave Ste 111, Hartford, CT 06105
Phone: 860-523-8026    Fax: 860-523-7622
Mr. Henry F Fedus, DPM
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 21 Grand Street, Hartford, CT 06106
Phone: 860-550-7500    Fax: 860-550-7501
Miss Kristina Corvese Bystrak, DPM
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 114 Woodland St, Hartford, CT 06105
Phone: 860-714-5911    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.